For: | Qiu DK, Ma X, Peng YS, Chen XY. Significance of cyclooxygenase-2 expression in human primary hepatocellular carcinoma. World J Gastroenterol 2002; 8(5): 815-817 [PMID: 12378621 DOI: 10.3748/wjg.v8.i5.815] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v8/i5/815.htm |
Number | Citing Articles |
1 |
Jason Foster, Jennifer Black, Charles LeVea, Thaer Khoury, Boris Kuvshinoff, Miland Javle, John F. Gibbs. COX-2 Expression in Hepatocellular Carcinoma is an Initiation Event; While EGF Receptor Expression with Downstream Pathway Activation is a Prognostic Predictor of Survival. Annals of Surgical Oncology 2007; 14(2): 752 doi: 10.1245/s10434-006-9123-8
|
2 |
María de Luján Alvarez, Florencia Lorenzetti. Role of eicosanoids in liver repair, regeneration and cancer. Biochemical Pharmacology 2021; 192: 114732 doi: 10.1016/j.bcp.2021.114732
|
3 |
Hong-Xia Li, Xin-Ming Chang, Zheng-Jun Song, Shui-Xiang He. Correlation between expression of cyclooxygenase-2 and angiogenesis in human gastric adenocarcinoma. World Journal of Gastroenterology 2003; 9(4): 674-677 doi: 10.3748/wjg.v9.i4.674
|
4 |
Denise M. Haynik, Richard A. Prayson. Immunohistochemical Expression of Cyclooxygenase 2 in Follicular Carcinomas of the Thyroid. Archives of Pathology & Laboratory Medicine 2005; 129(6): 736 doi: 10.5858/2005-129-736-IEOCIF
|
5 |
Il Han Song, Suk Bae Kim, Hyun Duk Shin, Ha Yan Kang, Eun Young Kim. NS-398 induces caspase-dependent, mitochondria-mediated intrinsic apoptosis of hepatoma cells. Advances in Bioscience and Biotechnology 2012; 3(06): 649 doi: 10.4236/abb.2012.326084
|
6 |
Christina Ziemann, Armin Riecke, Gudrun Rüdell, Elke Oetjen, Hans J. Steinfelder, Christian Lass, Georg F. Kahl, Karen I. Hirsch-Ernst. The Role of Prostaglandin E Receptor-Dependent Signaling via cAMP inMdr1bGene Activation in Primary Rat Hepatocyte Cultures. Journal of Pharmacology and Experimental Therapeutics 2006; 317(1): 378 doi: 10.1124/jpet.105.094193
|
7 |
Shigeaki Mizuno, Kimitoshi Kato, Akemi Hashimoto, Masahiko Sugitani, Aleemuzzaman Sheikh, Sachiko Komuro, Toyoharu Jike, Ariyoshi Iwasaki, Yasuyuki Arakawa, Norimichi Nemoto. Expression of cyclo‐oxygenase‐2 in gastrointestinal carcinoid tumors. Journal of Gastroenterology and Hepatology 2006; 21(8): 1313 doi: 10.1111/j.1440-1746.2005.04153.x
|
8 |
A. Vecchini, V. Ceccarelli, F. Susta, P. Caligiana, P. Orvietani, L. Binaglia, G. Nocentini, C. Riccardi, G. Calviello, P. Palozza, N. Maggiano, P. Di Nardo. Dietary α-linolenic acid reduces COX-2 expression and induces apoptosis of hepatoma cells. Journal of Lipid Research 2004; 45(2): 308 doi: 10.1194/jlr.M300396-JLR200
|
9 |
Shengbao Li, Dean Tian, Pei Fei, Yuanjun Gao, Zihua Chen, Qiang Wang, Qiang Tong. A Cyclooxygase-2 Inhibitor NS-398-Enhanced Apoptosis of Esophageal Carcinoma Cell EC9706 by Adjusting Expression of Survivin and Caspase-3. Cancer Investigation 2011; 29(2): 102 doi: 10.3109/07357907.2010.543209
|
10 |
Óscar Núñez Martínez, Gerardo Clemente Ricote, Carmelo García Monzón. Papel de la ciclooxigenasa 2 en la patogenia de las enfermedades del hígado. Medicina Clínica 2003; 121(19): 743 doi: 10.1016/S0025-7753(03)74082-2
|
11 |
Soon Ha Kwon, Soung Won Jeong, Jae Young Jang, Ji Eun Lee, Sae Hwan Lee, Sang Gyune Kim, Young Seok Kim, Young Deok Cho, Hong Soo Kim, Boo Sung Kim, So-Young Jin. Cyclooxygenase-2 and vascular endothelial growth factor in chronic hepatitis, cirrhosis and hepatocellular carcinoma. Clinical and Molecular Hepatology 2012; 18(3): 287 doi: 10.3350/cmh.2012.18.3.287
|
12 |
Dimitrios Papakonstantinou, Anna Paspala, Emmanouil Pikoulis, Despoina N Perrea, Anastasios Machairas, Georgios Agrogiannis, Nikolaos Machairas, Paulos Patapis, Nikolaos J Zavras. The Modulating Effect of Ursodeoxycholic Acid on Liver Tissue Cyclooxygenase-2 Expression Following Extended Hepatectomy. Cureus 2021; doi: 10.7759/cureus.15500
|
13 |
Shao-Shan Wang, Ti Zhang, Xi-Lu Wang, Li Hong, Qing-Hui Qi. Effect of arsenic trioxide on rat hepatocarcinoma and its renal cytotoxicity. World Journal of Gastroenterology 2003; 9(5): 930-935 doi: 10.3748/wjg.v9.i5.930
|
14 |
Shigeaki Mizuno, Kimitoshi Kato, Akemi Hashimoto, Masahiko Sugitani, Aleemuzzaman Sheikh, Sachiko Komuro, Toyoharu Jike, Ariyoshi Iwasaki, Yasuyuki Arakawa, Norimichi Nemoto. Expression of cyclo-oxygenase-2 in gastrointestinal carcinoid tumors. Journal of Gastroenterology and Hepatology 2006; 0(0): 060606032707089 doi: 10.1111/j.1440-1746.2006.04153.x
|
15 |
Ming-Yi Li, Hua Deng, Jia-Ming Zhao, Dong Dai, Xiao-Yu Tan. PPARγ pathway activation results in apoptosis and COX-2 inhibition in HepG2 cells. World Journal of Gastroenterology 2003; 9(6): 1220-1226 doi: 10.3748/wjg.v9.i6.1220
|
16 |
Yong-Jiang Xu, Zhaojun Zheng, Chen Cao, Jinwei Li, Yuanfa Liu. Bioanalytical insights into the association between eicosanoids and pathogenesis of hepatocellular carcinoma. Cancer and Metastasis Reviews 2018; 37(2-3): 269 doi: 10.1007/s10555-018-9747-8
|
17 |
Lydia Giannitrapani, Sabrina Ingrao, Maurizio Soresi, Ada Maria Florena, Emanuele La Spada, Luigi Sandonato, Natale D'Alessandro, Melchiorre Cervello, Giuseppe Montalto. Cyclooxygenase‐2 Expression in Chronic Liver Diseases and Hepatocellular Carcinoma. Annals of the New York Academy of Sciences 2009; 1155(1): 293 doi: 10.1111/j.1749-6632.2009.03698.x
|
18 |
Bin Xiong, Tao-Jiao Sun, Wei-Dong Hu, Fu-Lin Cheng, Min Mao, Yun-Feng Zhou. Expression of cyclooxygenase-2 in colorectal cancer and its clinical significance. World Journal of Gastroenterology 2005; 11(8): 1105-1108 doi: 10.3748/wjg.v11.i8.1105
|
19 |
Marco Breinig, Ralf Rieker, Eva Eiteneuer, Tina Wertenbruch, Anke Maria Haugg, Burkhard Maria Helmke, Peter Schirmacher, Michael André Kern. Differential expression of E‐prostanoid receptors in human hepatocellular carcinoma. International Journal of Cancer 2008; 122(3): 547 doi: 10.1002/ijc.23098
|
20 |
Magda Hamzawy, Laila Elsaid, Asmaa Shams, Laila Rashid, Soheir Mahfouz, Nivin Sharawy. Study of the Effects of Cyclooxygenase-2 Inhibitor on the Promotion of Hepatic Tumorigenesis in Rats Fed a High Fat Diet. Journal of Clinical and Experimental Hepatology 2015; 5(1): 14 doi: 10.1016/j.jceh.2014.12.010
|
21 |
Gary J. Kelloff, Scott M. Lippman, Andrew J. Dannenberg, Caroline C. Sigman, Homer L. Pearce, Brian J. Reid, Eva Szabo, V. Craig Jordan, Margaret R. Spitz, Gordon B. Mills, Vali A. Papadimitrakopoulou, Reuben Lotan, Bharat B. Aggarwal, Robert S. Bresalier, Jeri Kim, Banu Arun, Karen H. Lu, Melanie E. Thomas, Helen E. Rhodes, Molly A. Brewer, Michele Follen, Dong M. Shin, Howard L. Parnes, Jill M. Siegfried, Alison A. Evans, William J. Blot, Wong-Ho Chow, Patricia L. Blount, Carlo C. Maley, Kenneth K. Wang, Stephen Lam, J. Jack Lee, Steven M. Dubinett, Paul F. Engstrom, Frank L. Meyskens, Joyce O'Shaughnessy, Ernest T. Hawk, Bernard Levin, William G. Nelson, Waun Ki Hong. Progress in Chemoprevention Drug Development: The Promise of Molecular Biomarkers for Prevention of Intraepithelial Neoplasia and Cancer—A Plan to Move Forward. Clinical Cancer Research 2006; 12(12): 3661 doi: 10.1158/1078-0432.CCR-06-1104
|
22 |
Soung Won Jeong, Jae Young Jang, Sae Hwan Lee, Sang Gyun Kim, Young Koog Cheon, Young Seok Kim, Young Deok Cho, Hong Soo Kim, Joon Seong Lee, So-Young Jin, Chan Sup Shim, Boo Sung Kim. Increased Expression of Cyclooxygenase-2 is Associated with the Progression to Cirrhosis. The Korean Journal of Internal Medicine 2010; 25(4): 364 doi: 10.3904/kjim.2010.25.4.364
|
23 |
Dong-Sheng Huang, Ke-Zhen Shen, Jian-Feng Wei, Ting-Bo Liang, Shu-Sen Zheng, Hai-Yang Xie. Specific COX-2 inhibitor NS398 induces apoptosis in human liver cancer cell line HepG2 through BCL-2. World Journal of Gastroenterology 2005; 11(2): 204-207 doi: 10.3748/wjg.v11.i2.204
|
24 |
Bin Xiong, Tao-Jiao Sun, Hong-Yin Yuan, Ming-Bo Hu, Wei-Dong Hu, Fu-Lin Cheng. Cyclooxygenase-2 expression and angiogenesis in colorectal cancer. World Journal of Gastroenterology 2003; 9(6): 1237-1240 doi: 10.3748/wjg.v9.i6.1237
|
25 |
K J Schmitz, J Wohlschlaeger, H Lang, G C Sotiropoulos, G M Kaiser, K W Schmid, H A Baba. Cyclo-oxygenase-2 overexpression is a feature of early and well-differentiated hepatocellular carcinoma with a favourable prognosis. Journal of Clinical Pathology 2009; 62(8): 690 doi: 10.1136/jcp.2009.065888
|
26 |
Xiuci Yan, Xuenan Chen, Xiaohao Xu, Jianzeng Liu, Chunge Fu, Daqing Zhao, Weimin Zhao, Rui Ma, Liwei Sun. Mechanism Underlying p-Coumaric Acid Alleviation of Lipid Accumulation in Palmitic Acid-Treated Human Hepatoma Cells. Journal of Agricultural and Food Chemistry 2020; 68(12): 3742 doi: 10.1021/acs.jafc.0c00280
|
27 |
Il Han Song, Dong Woo Kim, Ki Chul Shin, Hyun Duk Shin, Se Young Yun, Suk Bae Kim, Jung Eun Shin, Hong Ja Kim, Eun Young Kim. Down-regulation of survivin in growth inhibition of hepatoma cells induced by a selective cyclooxygenase-2 inhibitor. The Korean Journal of Hepatology 2008; 14(3): 351 doi: 10.3350/kjhep.2008.14.3.351
|
28 |
Naglaa F. Abbas, Manal A. Badawi, Wafaa E. Abd El-Aal, Sonia L. El-Sharkawy. Morphometric analysis and immunohistochemical expression of cyclooxygenase-2 in hepatitis C virus-induced fibrosis. Medical Research Journal 2013; 12(2): 95 doi: 10.1097/01.MJX.0000437951.43008.8d
|